Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2003
03/25/2003US6538010 Compounds may be used to treat a variety of other conditions and disease states and reagents for preventing smoking addiction. The present invention also relates to methods and reagents for treating nicotine addiction.
03/25/2003US6538000 9-(3-chloro-4-hydroxyphenyl)-5,6,7,9-tetrahydropyrazolo(5,1-b) quinazoline-8(4H)-one;for cardiovascular disorders
03/25/2003US6537999 Pyrimidine derivatives and methods of making and using these derivatives
03/25/2003US6537998 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/25/2003US6537712 Dry development systems
03/21/2003WO2002026230A1 Remedies for inflammatory bowel diseases
03/21/2003CA2423423A1 Medecines of ulcerative colitis
03/20/2003WO2003022861A1 Process for the preparation of rebeccamycin and analogs thereof
03/20/2003WO2003022856A1 Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases
03/20/2003WO2003022851A1 Process for the preparation of highly pure triethylene diamine
03/20/2003WO2003022850A1 IMIDAZO[1,2-a]PYRIMIDINES AND FUNGICIDE COMPOSITIONS CONTAINING THE SAME
03/20/2003WO2003022848A2 Process for the preparation of diketopyrrolopyrroles
03/20/2003WO2003022847A2 Process for the direct preparation of pyrrolo[3,4-c]pyrroles
03/20/2003WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003WO2003022804A2 Method for the preparation of crystalline tetrahydrobenzothiepines
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003002672A3 Fluorescent diketopyrrolopyrroles
03/20/2003WO2002096366A3 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
03/20/2003WO2002035454A9 Fluoroscopic registration artifact with optical and/or magnetic markers
03/20/2003WO2002030886A3 Heterocyclic angiogenesis inhibitors
03/20/2003WO2002012245B1 Azabicyclic derivatives and their therapeutic use
03/20/2003US20030055268 Hair dyes
03/20/2003US20030055250 Pteridine compounds for the treatment of psoriasis
03/20/2003US20030055094 Bicyclic modulators of androgen receptor function
03/20/2003US20030055071 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV
03/20/2003US20030055069 For combating a fungus at a locus
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055060 Imidazo-triazine derivatives as ligands for GABA receptors
03/20/2003US20030055059 For therapy of psychiatric disorders and neurological diseases including affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055047 For prevention and/or suppression of preterm labor, suppression of labor at term prior to caesarean delivery, and for the treatment of dysmenorrhea; useful in enhancing fertility rates
03/20/2003US20030055046 Novel pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055043 Substituted azabicyclic moieties for the treatment of disease
03/20/2003US20030055042 Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
03/20/2003US20030055032 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage
03/20/2003US20030054957 Combining functional material to be precipitated as nanoscale particles and surface active material in compressed carbon dioxide phase with density of 0.1 g/cc, rapidly depressurizing compressed phase, thereby precipitating dispersed function
03/20/2003US20030054028 Sustained releasing drug in situ
03/20/2003US20030053949 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/20/2003CA2460330A1 Method for the preparation of crystalline tetrahydrobenzothiepines
03/20/2003CA2460075A1 Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases
03/20/2003CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003CA2457710A1 Process for the direct preparation of pyrrolo¬3,4-c|pyrroles
03/19/2003EP1292586A1 Process for the preparation of pyrazolopyrimidinones
03/19/2003EP1292561A1 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1149106B1 4,5-azolo-oxindoles
03/19/2003EP1114049B1 3-bicycloindole compounds as 5-ht1d receptor ligands
03/19/2003EP1042314B1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404471A Substituted piperazine compounds
03/19/2003CN1404393A Use of a compound for preparing a drug
03/19/2003CN1403460A Synthesis of monocrystal porphyrin
03/19/2003CN1403459A Prepn of oxidizing and desulfurizing catalyst phthalocyanine cobalt sulfonate
03/19/2003CN1403458A (8S,18S)-1,4,10,13,16-pentazatricyclo [16.3.0.0 4.8] heneicosane-9,17-diketone and its prepn process
03/18/2003US6534512 Dideoxycarbocyclic nucleosides
03/18/2003US6534511 The use of certain 6-arylpyrazolo(3,4-d)pyrimidin-4-ones, 2 arylquinazolin-4-ones, 2-arylpurin-6-ones and 2-arylpyrido(3,2- d)pyrimidin-4-ones, or a pharmaceutically acceptable salt thereof, forsexual disorders
03/18/2003US6534505 Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same
03/18/2003US6534491 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
03/18/2003US6534250 Photo-reactive benzocyclobutenones and polymers thereform for self-photocuring, photo-crosslinking and photopatterning without catalysts
03/18/2003US6534040 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/18/2003CA2272705C Fused bicyclic pyrimidine derivatives
03/18/2003CA2269994C 7-hetero-bicyclo¬2.2.1|-heptanes
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/13/2003WO2003020731A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
03/13/2003WO2003020724A1 Polycyclic guanine phosphodiesterase v inhibitors
03/13/2003WO2003020723A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINE DERIVATIVE
03/13/2003WO2003020722A1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
03/13/2003WO2003020721A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/13/2003WO2003020720A1 Sildenafil maleate
03/13/2003WO2003020309A2 Compound
03/13/2003WO2003020287A2 Methods for the treatment of chronic pain anc compositions therefor
03/13/2003WO2003020267A1 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
03/13/2003WO2003020222A2 PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE
03/13/2003WO2002100354A3 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
03/13/2003WO2002098855A3 1,2,4-TRIAZOLO[4,3-a][1,3,5]TRIAZINE-3,5,7-SUBSTITUTED PRECURSOR, AND PROCESS, AND COMPOUNDS THEREFROM
03/13/2003WO2002088080A3 Dual inhibitors of pde 7 and pde 4
03/13/2003WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002015893A3 Treatment of wounds
03/13/2003US20030050331 Cytotoxic agents
03/13/2003US20030050301 A drug mixture additionally comprising an antihypertensive agent or it's prodrug and a carrier, vehicle or diluent
03/13/2003US20030050297 Administering to a mammal, a low molecular weight antioxidants, mimetics of superoxide dismutase
03/13/2003US20030050296 Photodynamic porphyrin antimicrobial agents
03/13/2003CA2458399A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
03/12/2003EP1289996A1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
03/12/2003EP1289995A2 Fungicidal triazolopyrimid-7-ylideneamines
03/12/2003EP1289994A1 PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY 1,2,4]TRIAZOLO 1,5-c]PYRIMIDINE
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289992A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
03/12/2003EP1289987A1 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof
03/12/2003EP1289968A1 Cyclic urea compounds and preparation thereof
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289963A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289934A1 Method for producing amides or esters
03/12/2003EP1243575A9 Preparation of esters in the presence of onium salts
1 ... 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 ... 573